Skip to main content
All lobbying filings

SOLENO THERAPEUTICS, INC.

SOLENO THERAPEUTICS, INC. filed a registration for SOLENO THERAPEUTICS, INC. on May 4, 2026.

Lobbying for SOLENO THERAPEUTICS, INC. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.

All filings by SOLENO THERAPEUTICS, INC. · Everything SOLENO THERAPEUTICS, INC. has reported

 Filing · LD-1 registration Registration
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted May 4, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
California

Official filing document

 Lobbying activity 7
Financial Institutions/Investments/Securities

H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption

Health Issues

H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption

Medicare/Medicaid

H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption

Insurance

H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption

Pharmacy

H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption

Trade (domestic/foreign)

H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption

Economics/Economic Development

H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption

 Bills named in this filing 4
  • H.R. 7118
    Genomic Answers for Children’s Health Act of 2026
  • H.R. 1414
    Cameron’s Law
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • S. 832
    EPIC Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem